DuoM Tablet 40/5 mg

Adult dose

The recommended dose of this medication is 1 tablet once daily, to be taken with water without regard to meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with renal impairment, dose adjustment is not required for mild to moderate renal impairment, but patients with severe renal impairment should start therapy at a lower dose and gradually increase it. For patients with liver impairment, the daily dosage of telmisartan should not exceed 40 mg for mild to moderate liver impairment.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, so the administration of this medication is not recommended.

This medication may pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or those who may become pregnant. It should not be administered to individuals allergic to the active ingredients or related compounds, patients with severe liver impairment, severe hypotension, significantly compromised cardiac function, or unstable heart failure following acute myocardial infarction. Patients with primary aldosteronism, certain heart valve diseases, liver disorders, gastrointestinal diseases, renal vascular hypertension, those on dialysis, and the elderly require special caution when using this medication. Common side effects include dizziness and peripheral edema, while serious side effects such as syncope have been reported rarely. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with a safer treatment. Hypotension may occur, so patients with dehydration or low salt levels should improve their condition before taking the medication and closely monitor their blood pressure. This medication can increase serum potassium levels, so patients with impaired renal function or heart failure should have their potassium levels regularly checked through blood tests. It is important for patients with impaired renal function to periodically monitor their kidney function and serum electrolyte levels while on this medication. Patients with heart disease should be cautious, as there may be an increased risk of angina or myocardial infarction after taking this medication. It is not recommended for breastfeeding women, and they should avoid taking it if they are nursing. This medication can interact with other drugs, so patients should inform their healthcare provider of any other medications they are taking, especially potassium supplements or certain diuretics. Drowsiness or dizziness may occur while on this medication, so caution is advised when driving or operating dangerous machinery. In cases of overdose, symptoms may include hypotension, dizziness, and decreased heart function, and immediate medical attention is required. This medication is not recommended for children due to the lack of established safety and efficacy, and elderly patients should start at a lower dose and gradually increase it. Store this medication out of the reach of children and in a sealed condition to maintain product quality.

Serious side effects

Sepsis, thrombocytopenia, leukopenia, anaphylaxis, angioedema (with fatal outcomes), toxic skin rash, Stevens-Johnson syndrome, photosensitivity reaction, hepatitis, jaundice, elevated liver enzymes (with cholestasis), myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, vasculitis, respiratory distress, interstitial lung disease, pancreatitis, intestinal vascular edema, renal dysfunction (including acute renal failure), congestive heart failure, cerebral infarction

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius for efficacy.

Appearance

Biconvex oval double-coated tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)